RAPT Therapeutics, Inc. (RAPT) NASDAQ

28.92

-0.08(-0.28%)

Updated at November 11 09:30AM

Currency In USD

Valuation

Market Cap515.22M
Enterprise Value349.98M
P/E Ratio-7.4
PEG Ratio0.96
Price/Sales Ratio0
Price/Book Ratio5.15
Enterprise/Revenue0
Enterprise/EBITDA-4.04

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.64
Return On Equity-0.62

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-134.9M
Net Income-129.87M
Diluted EPS-25.49

Balance Sheet

Total Cash157.34M
Total Cash/Share5.84
Total Debt2.6M
Total Debt/Equity0.02
Current Ratio12.04
Book Value Per Share5.64

Price History

52-Week Change107.14
52-Week High42.39
52-Week Low5.66
Moving Average 50 Days24.28
Moving Average 200 Days12.84

Statistics

Average Volume379,787
Shares Outstanding16.54M
% Held by Institutions62.93

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:8
Last Split DateJune 17, 2025